Introduction to Clinical Pharmacology, 11th Edition
ORIGINAL TEST BANK STYLE-QUESTION BANK
Visovsky, Zambroski & Hosler | Chapters 1-23 | Volume A
1,200 Original Questions • Correct Answer After Every Question • Detailed Teaching Rationale
2026/2027 Updated Study Edition
Page 1
,Coverage
• Chapter 1: Pharmacology and the Nursing Process in LPN Practice
• Chapter 2: Legal, Regulatory, and Ethical Aspects of Drug Administration
• Chapter 3: Principles of Pharmacology
• Chapter 4: Drug Calculation: Preparing and Giving Drugs
• Chapter 5: Drugs for Bacterial Infections
• Chapter 6: Drugs for Tuberculosis, Fungal, and Parasitic Infections
• Chapter 7: Drugs for Viral and Retroviral Infections
• Chapter 8: Drugs for Allergy and Respiratory Problems
• Chapter 9: Drugs Affecting the Renal/Urinary and Cardiovascular Systems
• Chapter 10: Drugs for Central Nervous System Problems
• Chapter 11: Drugs for Mental Health
• Chapter 12: Drugs for Analgesia and Anesthesia
• Chapter 13: Drugs for Inflammation, Arthritis, and Gout
• Chapter 14: Drugs for Gastrointestinal Problems
• Chapter 15: Drugs for Immunization and Immunomodulation
• Chapter 16: Drugs Affecting the Hematologic System
• Chapter 17: Drugs for Cancer Treatment
• Chapter 18: Drugs for Reproductive Health
• Chapter 19: Drugs for Thyroid and Adrenal Problems
• Chapter 20: Drug Therapy for Diabetes
• Chapter 21: Drugs for Osteoporosis
• Chapter 22: Drugs for Eye and Ear Problems
• Chapter 23: Over-the-Counter Drug Therapy
Page 2
,Chapter 1: Pharmacology and the Nursing Process in LPN Practice
1. Which monitoring plan is most appropriate for a patient receiving half-life?
A. Time required for plasma concentration to decrease by about half during elimination.
B. Steady state often takes several half-lives.
C. Timing of levels for narrow-therapeutic-index drugs.
D. Estimate drug accumulation and time to steady state.
Answer: C Timing of levels for narrow-therapeutic-index drugs.
Rationale: Monitoring should target the desired response and predictable toxicities. For half-life, the
appropriate focus is: timing of levels for narrow-therapeutic-index drugs. This connects pharmacology to
patient safety rather than substituting an indication, mechanism, or teaching statement for an actual
monitoring plan. Clinical reasoning: first identify exactly what the stem is testing—such as drug class,
mechanism, indication, expected effect, adverse reaction, contraindication, monitoring priority, or
patient teaching—then select the option that answers that dimension most directly. Safety connection:
the correct response links pharmacology knowledge to prevention of medication error, recognition of
toxicity or deterioration, and appropriate follow-up. Why the distractors are incorrect: some alternatives
describe a related pharmacologic property or safety principle, while others do not answer the clinical
dimension requested or conflict with safe medication-use principles.
2. For exam review, which statement about first-pass metabolism indicates that the patient needs
additional teaching?
A. “I will follow this teaching: do not substitute routes without authorization.”
B. “I understand the clinical role includes: explain reduced bioavailability of some oral drugs.”
C. “I can ignore this precaution: do not assume oral and IV doses are equivalent.”
D. “I understand my care team may monitor: response after route/formulation changes.”
Answer: C “I can ignore this precaution: do not assume oral and IV doses are equivalent.”
Rationale: The incorrect statement dismisses an important safety point: do not assume oral and IV doses
are equivalent. The other statements appropriately distinguish the drug’s clinical role, patient teaching,
and monitoring. A patient should never be taught to ignore a meaningful precaution. Clinical reasoning:
first identify exactly what the stem is testing—such as drug class, mechanism, indication, expected
effect, adverse reaction, contraindication, monitoring priority, or patient teaching—then select the option
that answers that dimension most directly. Safety connection: the correct response links pharmacology
knowledge to prevention of medication error, recognition of toxicity or deterioration, and appropriate
follow-up. Why the distractors are incorrect: some alternatives describe a related pharmacologic
Page 3
, property or safety principle, while others do not answer the clinical dimension requested or conflict with
safe medication-use principles.
3. Which option best identifies an adverse-effect or safety concern associated with
pharmacodynamics?
A. Therapeutic and adverse responses.
B. Describe what a drug does to the body.
C. Dose-response relationships vary among patients.
D. Excess pharmacologic effect can become toxicity.
Answer: D Excess pharmacologic effect can become toxicity.
Rationale: The adverse-effect or safety concern highlighted for pharmacodynamics is: excess
pharmacologic effect can become toxicity. The remaining options describe related pharmacologic
concepts, teaching points, or monitoring considerations but do not answer the safety implication asked in
the stem. Clinical reasoning: first identify exactly what the stem is testing—such as drug class,
mechanism, indication, expected effect, adverse reaction, contraindication, monitoring priority, or
patient teaching—then select the option that answers that dimension most directly. Safety connection:
the correct response links pharmacology knowledge to prevention of medication error, recognition of
toxicity or deterioration, and appropriate follow-up. Why the distractors are incorrect: some alternatives
describe a related pharmacologic property or safety principle, while others do not answer the clinical
dimension requested or conflict with safe medication-use principles.
4. Which patient-teaching point is most important for therapeutic index
A. Describe margin between therapeutic and toxic exposure.
B. Clinician monitoring: drug levels and clinical response when indicated.
C. Adherence and interaction review are especially important.
D. Narrow-index drugs have smaller separation between effective and toxic concentrations.
Answer: C Adherence and interaction review are especially important.
Rationale: The most relevant patient-teaching or safety point associated with therapeutic index is:
adherence and interaction review are especially important. This teaching reduces preventable harm and
supports adherence. The other options are pharmacology facts or clinician-monitoring responsibilities,
not the requested patient-teaching point. Clinical reasoning: first identify exactly what the stem is
testing—such as drug class, mechanism, indication, expected effect, adverse reaction, contraindication,
monitoring priority, or patient teaching—then select the option that answers that dimension most
directly. Safety connection: the correct response links pharmacology knowledge to prevention of
Page 4
ORIGINAL TEST BANK STYLE-QUESTION BANK
Visovsky, Zambroski & Hosler | Chapters 1-23 | Volume A
1,200 Original Questions • Correct Answer After Every Question • Detailed Teaching Rationale
2026/2027 Updated Study Edition
Page 1
,Coverage
• Chapter 1: Pharmacology and the Nursing Process in LPN Practice
• Chapter 2: Legal, Regulatory, and Ethical Aspects of Drug Administration
• Chapter 3: Principles of Pharmacology
• Chapter 4: Drug Calculation: Preparing and Giving Drugs
• Chapter 5: Drugs for Bacterial Infections
• Chapter 6: Drugs for Tuberculosis, Fungal, and Parasitic Infections
• Chapter 7: Drugs for Viral and Retroviral Infections
• Chapter 8: Drugs for Allergy and Respiratory Problems
• Chapter 9: Drugs Affecting the Renal/Urinary and Cardiovascular Systems
• Chapter 10: Drugs for Central Nervous System Problems
• Chapter 11: Drugs for Mental Health
• Chapter 12: Drugs for Analgesia and Anesthesia
• Chapter 13: Drugs for Inflammation, Arthritis, and Gout
• Chapter 14: Drugs for Gastrointestinal Problems
• Chapter 15: Drugs for Immunization and Immunomodulation
• Chapter 16: Drugs Affecting the Hematologic System
• Chapter 17: Drugs for Cancer Treatment
• Chapter 18: Drugs for Reproductive Health
• Chapter 19: Drugs for Thyroid and Adrenal Problems
• Chapter 20: Drug Therapy for Diabetes
• Chapter 21: Drugs for Osteoporosis
• Chapter 22: Drugs for Eye and Ear Problems
• Chapter 23: Over-the-Counter Drug Therapy
Page 2
,Chapter 1: Pharmacology and the Nursing Process in LPN Practice
1. Which monitoring plan is most appropriate for a patient receiving half-life?
A. Time required for plasma concentration to decrease by about half during elimination.
B. Steady state often takes several half-lives.
C. Timing of levels for narrow-therapeutic-index drugs.
D. Estimate drug accumulation and time to steady state.
Answer: C Timing of levels for narrow-therapeutic-index drugs.
Rationale: Monitoring should target the desired response and predictable toxicities. For half-life, the
appropriate focus is: timing of levels for narrow-therapeutic-index drugs. This connects pharmacology to
patient safety rather than substituting an indication, mechanism, or teaching statement for an actual
monitoring plan. Clinical reasoning: first identify exactly what the stem is testing—such as drug class,
mechanism, indication, expected effect, adverse reaction, contraindication, monitoring priority, or
patient teaching—then select the option that answers that dimension most directly. Safety connection:
the correct response links pharmacology knowledge to prevention of medication error, recognition of
toxicity or deterioration, and appropriate follow-up. Why the distractors are incorrect: some alternatives
describe a related pharmacologic property or safety principle, while others do not answer the clinical
dimension requested or conflict with safe medication-use principles.
2. For exam review, which statement about first-pass metabolism indicates that the patient needs
additional teaching?
A. “I will follow this teaching: do not substitute routes without authorization.”
B. “I understand the clinical role includes: explain reduced bioavailability of some oral drugs.”
C. “I can ignore this precaution: do not assume oral and IV doses are equivalent.”
D. “I understand my care team may monitor: response after route/formulation changes.”
Answer: C “I can ignore this precaution: do not assume oral and IV doses are equivalent.”
Rationale: The incorrect statement dismisses an important safety point: do not assume oral and IV doses
are equivalent. The other statements appropriately distinguish the drug’s clinical role, patient teaching,
and monitoring. A patient should never be taught to ignore a meaningful precaution. Clinical reasoning:
first identify exactly what the stem is testing—such as drug class, mechanism, indication, expected
effect, adverse reaction, contraindication, monitoring priority, or patient teaching—then select the option
that answers that dimension most directly. Safety connection: the correct response links pharmacology
knowledge to prevention of medication error, recognition of toxicity or deterioration, and appropriate
follow-up. Why the distractors are incorrect: some alternatives describe a related pharmacologic
Page 3
, property or safety principle, while others do not answer the clinical dimension requested or conflict with
safe medication-use principles.
3. Which option best identifies an adverse-effect or safety concern associated with
pharmacodynamics?
A. Therapeutic and adverse responses.
B. Describe what a drug does to the body.
C. Dose-response relationships vary among patients.
D. Excess pharmacologic effect can become toxicity.
Answer: D Excess pharmacologic effect can become toxicity.
Rationale: The adverse-effect or safety concern highlighted for pharmacodynamics is: excess
pharmacologic effect can become toxicity. The remaining options describe related pharmacologic
concepts, teaching points, or monitoring considerations but do not answer the safety implication asked in
the stem. Clinical reasoning: first identify exactly what the stem is testing—such as drug class,
mechanism, indication, expected effect, adverse reaction, contraindication, monitoring priority, or
patient teaching—then select the option that answers that dimension most directly. Safety connection:
the correct response links pharmacology knowledge to prevention of medication error, recognition of
toxicity or deterioration, and appropriate follow-up. Why the distractors are incorrect: some alternatives
describe a related pharmacologic property or safety principle, while others do not answer the clinical
dimension requested or conflict with safe medication-use principles.
4. Which patient-teaching point is most important for therapeutic index
A. Describe margin between therapeutic and toxic exposure.
B. Clinician monitoring: drug levels and clinical response when indicated.
C. Adherence and interaction review are especially important.
D. Narrow-index drugs have smaller separation between effective and toxic concentrations.
Answer: C Adherence and interaction review are especially important.
Rationale: The most relevant patient-teaching or safety point associated with therapeutic index is:
adherence and interaction review are especially important. This teaching reduces preventable harm and
supports adherence. The other options are pharmacology facts or clinician-monitoring responsibilities,
not the requested patient-teaching point. Clinical reasoning: first identify exactly what the stem is
testing—such as drug class, mechanism, indication, expected effect, adverse reaction, contraindication,
monitoring priority, or patient teaching—then select the option that answers that dimension most
directly. Safety connection: the correct response links pharmacology knowledge to prevention of
Page 4
